Today: 30 June 2026
Browse Category

Stock Market 17 January 2026

Spotify stock slips as Premium price hike lands; analysts trim targets

Spotify stock slips as Premium price hike lands; analysts trim targets

NEW YORK, Jan 16, 2026, 19:00 EST — Trading after the bell. Shares of Spotify Technology S.A. slipped 0.7% to $504.50 on Friday and barely moved in after-hours trading, adding to a two-day decline totaling roughly 4.6% following Thursday’s 3.95% fall. The stock fluctuated between $500.82 and $511.13 during the session, with roughly 3.7 million shares traded.
17 January 2026
·
Intuit stock drops again after TurboTax NYC push as Jefferies calls the slide “overdone”

Intuit stock drops again after TurboTax NYC push as Jefferies calls the slide “overdone”

NEW YORK, Jan 16, 2026, 18:37 ET — After-hours Intuit Inc shares dropped 1.7% on Friday to close at $545.29, marking their sixth consecutive day of losses, then held steady in after-hours trading. The TurboTax and QuickBooks parent saw intraday swings between $535.15 and $555.79, now sitting roughly 33% below its 52-week peak reached on July 30. Trading volume hit about 4.7 million shares, well above the 50-day average. This came as Adobe slid, while Paychex and Oracle finished higher amid a slightly softer broader market.
17 January 2026
·
Dow, S&P 500, Nasdaq end week lower — chip rally, bank jitters, and next week’s big tests

Dow, S&P 500, Nasdaq end week lower — chip rally, bank jitters, and next week’s big tests

New York, Jan 16, 2026, 18:57 EST — After-hours U.S. stocks finished Friday nearly unchanged, but all three major indexes logged weekly losses as the fourth-quarter earnings season kicked off. The Dow dropped 83.11 points, or 0.17%, to 49,359.33. The S&P 500 edged down 4.46 points, or 0.06%, to 6,940.01, while the Nasdaq slipped 14.63 points, also 0.06%, to 23,515.39. For the week, the S&P 500 fell 0.38%, the Nasdaq lost 0.66%, and the Dow declined 0.29%. Small caps held up, with the Russell 2000 closing at a fresh record high. “Most investors will take that as a win,” said Anthony Saglimbene of Ameriprise Financial. Granite Wealth’s Bruce Zaro described mid-January as “pretty choppy.”
17 January 2026
TSX ends week at fresh records after Canada-China trade deal and oil rebound — CPI next

TSX ends week at fresh records after Canada-China trade deal and oil rebound — CPI next

Toronto, January 16, 2026, 18:43 EST — Market closed Canada’s benchmark S&P/TSX Composite closed at a record 33,040.55 on Friday, up 0.04% on the day and 1.3% for the week. Energy rose 0.9% as U.S. crude settled up 0.4% at $59.44, and Prime Minister Mark Carney said an initial Canada-China trade deal would cut tariffs on electric vehicles and canola. Edward Jones strategist Angelo Kourkafas said “markets are rational” as interest-rate swaps, a derivatives market, priced two U.S. rate cuts this year; MDA Space jumped 14.5% after Morgan Stanley lifted its rating to “overweight,” meaning it expects the stock to outperform.
17 January 2026
·
Constellation Energy (CEG) stock dives on White House push to cap PJM power-market prices

Constellation Energy (CEG) stock dives on White House push to cap PJM power-market prices

NEW YORK, Jan 16, 2026, 18:10 EST — After-hours Shares of Constellation Energy Corporation plunged on Friday, slipping as much as 9.8% to $307.71 in after-hours trading after fluctuating between $350.62 and $300.45 earlier. The selloff came after the White House urged PJM Interconnection—the country’s largest electric grid serving 67 million customers across 13 states plus Washington, D.C.—to hold a one-time emergency procurement auction for new power plants and impose limits on earnings for existing plants in PJM’s capacity market, which pays generators to stay on standby. This follows a recent PJM capacity auction that saw prices surge over 800% compared to last year. Pennsylvania Governor Josh Shapiro criticized PJM for being “too damn slow” amid rising power bills.
17 January 2026
··
1 … 715 716 717 718 719 … 1,605

Stock Market Today

  • Abivax Jumps 36% After Cancer Safety Fear Eases for Obefazimod
    June 30, 2026, 8:33 AM EDT. Abivax shares climbed 35.77% to 113.10 euros in Paris after new data on its ulcerative colitis drug obefazimod eased cancer safety worries. The updated look, now covering 1,704 patient-years, showed cancer rates tracking with what's expected for the disease, and helped shore up obefazimod's safety profile. Shares had been under pressure after the 50 mg group in Phase 3 turned up higher malignancy numbers. Safety focus stayed high but efficacy held up, with remission topping 50% across doses and relapses. Abivax targets a U.S. FDA filing in the fourth quarter of 2026. In U.S. extended trading, shares picked up 26.4%, narrowing their year-to-date decline to 6.06%.
Go toTop